Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ASBP compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ASBP
Aspire Biopharma Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ASBP
Aspire Biopharma Holdings, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
ASBP
No earnings history for ASBP.
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
= implied
ASBP realized, solid
LLY realized, hatched
One scale, both sides: full bar = 11%
× = |realized| ÷ implied
Source: market data
ASBP
Aspire Biopharma Holdings, Inc.
Change
7.24
▲
+7.10%
· post 7.84
Mkt cap
$9.5M
Revenue
$20,732
Q2 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
ASBP
Aspire Biopharma Holdings, Inc.
vs
LLY
ELI Lilly & Co
7.24
▲
+7.10%
post 7.84
Price
1,360.90
▼
−0.28%
post 1,358.90
$9.5M
Mkt cap
$1.2T
Q2 FY26
$20,732
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
ASBP
7.24
▲
+7.10%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26